Fortress - FBIO Net earnings per one share for the last twelve months

Fortress Biotech, Inc. (FBIO) manages its assets using specialized software, although patent expertise remains with human specialists. The company's revenues are limited by insurance terms and licensing payments, with the current figure standing at 1609.20. The business relies on an incubator model, transforming scientific ideas into marketable drugs. This price chart clearly demonstrates the earnings per share (EPS) dynamics for Fortress Biotech, Inc. (FBIO).
Financial and market metric breakdowns for Fortress Biotech, Inc. (FBIO)

The Fortress Biotech, Inc. (FBIO) model, based on the creation of subsidiary startups and the recruitment of M&A experts, directly impacts the efficiency of asset capitalization. Current EPS YoY TTM dynamics reflect the annual change in earnings per share over a rolling period, allowing for a comparison between the company's market value and its actual ability to generate net income to identify fundamental undervaluation or business overheating.